Patient-reported health preferences of anticoagulant-related outcomes

Ye Wang, Feng Xie, Ming Chai Kong, Lai Heng Lee, Heng Joo Ng, Yu Ko

研究成果: 雜誌貢獻文章同行評審

7 引文 斯高帕斯(Scopus)

摘要

Strokes can have a catastrophic impact on patients’ health-related quality of life (HRQoL). In addition to warfarin, two novel oral anticoagulants, i.e., dabigatran and rivaroxaban, have been approved to prevent strokes. This study aimed to use direct measures to elicit patient-reported utilities (i.e., preferences) for anticoagulant-related outcomes. A cross-sectional survey was administered to 100 patients taking warfarin in an anticoagulation clinic. Utilities for six long-term and four short-term anticoagulant-related health states were elicited by the visual analogue scale (VAS) and standard gamble (SG) methods. Health states with the highest SG-derived mean utility values were “well on rivaroxaban” (mean ± SD = 0.90 ± 0.15), “well on warfarin” (0.86 ± 0.17), and “well on dabigatran” (0.83 ± 0.18). Approximately half of the patients considered major ischemic stroke (−1.57 ± 6.77) and intracranial hemorrhage (−1.99 ± 6.98) to be worse than death. The percentages of patients who considered a particular health state worse than death ranged from 0 to 55 % among various health states assessed. The VAS had similar findings. Good logical consistency was observed in both VAS- and SG-derived utility values. Ischemic stroke and intracranial hemorrhage had a significant impact on patients’ HRQoL. Greater variation in patients’ preferences was observed for more severely impaired health states, indicating the need for individualized medical decision-making. In this study, both long-term and short-term health states were included in the utility assessment. The findings of this study can be used in cost-utility analysis of future anticoagulation therapies.

原文英語
頁(從 - 到)268-273
頁數6
期刊Journal of Thrombosis and Thrombolysis
40
發行號3
DOIs
出版狀態已發佈 - 十月 24 2015

ASJC Scopus subject areas

  • 血液學
  • 心臟病學與心血管醫學

指紋

深入研究「Patient-reported health preferences of anticoagulant-related outcomes」主題。共同形成了獨特的指紋。

引用此